BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  ImmuCell Announces Profitable Financial Results

  August 13, 2012

   · 

  6 min read
• Remedent, Inc. Announces Conference Call to be Held on Monday, August 13, 2012 at 12 PM EDT to Give an Update on Recent Strategic Developments

  August 13, 2012

   · 

  2 min read
• Drug Development

  Protalix Biotherapeutics, Inc. Receives FDA IND Clearance to Initiate a Phase I/II Study of Fabry Disease Patients With PRX-102, a Modified Enzyme Replacement Therapy

  August 13, 2012

   · 

  1 min read
• Business

  Pluristem Therapeutics Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research

  August 13, 2012

   · 

  1 min read
• Business

  Galectin Therapeutics Reports Second Quarter 2012 Financial Results

  August 13, 2012

   · 

  1 min read
• Biotech Bay

  Intuitive Surgical, Inc. Reports New Employee Option Grants for August, 2012

  August 13, 2012

   · 

  1 min read
• Business

  Verastem, Inc. Reports Second Quarter 2012 Financial and Corporate Results

  August 13, 2012

   · 

  1 min read
• Drug Development

  Bionor Pharma ASA Release: Study of Vacc-4x Combined With Celgene’s Revlimid® (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin

  August 13, 2012

   · 

  5 min read
• U.S. Army Institute for Surgical Research to Present Results of OxyBand Wound Dressing™ Clinical Trial at Military Health System Research Symposium in Fort Lauderdale, Florida August 13-16, 2012

  August 13, 2012

   · 

  1 min read
• BioMimetic Therapeutics, Inc. to Present at the Wedbush PacGrow Life Sciences Management Access Conference

  August 13, 2012

   · 

  1 min read